[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Journal Information::
Articles archive::
Publication Ethics::
Peer Review Process::
Indexing Databases::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Google Scholar Metrics

Citation Indices from GS

AllSince 2018

Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Registered in



:: Volume 30, Issue 2 (6-2022) ::
Journal of Ilam University of Medical Sciences 2022, 30(2): 97-104 Back to browse issues page
Investigation of the Relationship between the rs8192688 Polymorphism of the FABP-4 Gene and Cardiovascular Disease Susceptibility in Type 2 Diabetic Patients in Ilam Province, Iran
Amin Bakhtiyari1 , Salar Bakhtiari * 2, Maryam Peymani1 , Karimeh Haghani1 , Siros Norozi3
1- Dept of Biology, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran
2- Dept of Biology, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran , bakhtiyaribio@gmail.com
3- Dept of Cardiology, Ilam University of Medical Sciences, Ilam, Iran
Abstract:   (848 Views)
Introduction: Cardiovascular disease (CVD) is the most common cause of death in patients with type 2 diabetes (T2D). The association between diabetes and cardiovascular disease is complex and multifaceted. This study aimed to investigate the possible association between rs8192688 Polymorphism of the FABP-4 gene and the CVD susceptibility in T2DM patients in Ilam Province, Iran.
Material & Methods: The statistical population consisted of 210 cases (T2D patients with CVD [n=70], T2D patients without CVD [n=70], and healthy controls [n=70]). The frequency of polymorphisms was investigated using the Tetra-Primer-ARMS-PCR method.
(Ethic code: IR.IAU.SHK.1399.011)
Findings: The results showed that TG, HDL-C, and LDL-C in the T2D group with CVD were significantly increased, compared to those in the T2D group (P<0.05). The frequency rates of the CT genotype in the control, T2D, and T2D with CVD groups were 26%, 24%, and 295 (P=0.16), respectively. Moreover, the frequency rates of the TT genotype were 6%, 4%, and 4% (P=0.12), and the frequency rates of the T allele were 19%, 16%, and 19% (P=0.09), respectively. There was no significant relationship between this polymorphism and the studied groups.
Discussion & Conclusion: The results showed that TG, LDL-C, and HDL-C could have a role in the development of CVD in T2D patients; however, the rs8192688 polymorphism of the FABP4 gene was not involved in the development of CVD in T2D patients.
Keywords: Cardiovascular disease, FABP-4, Polymorphism, Type 2 diabetes
Full-Text [PDF 1119 kb]   (283 Downloads)    
Type of Study: Applicable | Subject: biochemistry
Received: 2021/07/17 | Accepted: 2021/07/18 | Published: 2022/06/5
1. 1. Rizza RA. Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes.implications for therapy. Diabetes 2010. 59:2697-707. doi: 10.2337/db10-1032
2. 2. Riserus U, Willett WC, Hu FB. Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 2009; 48:44-51. doi: 10.1016/j.plipres.2008.10.002
3. 3. van 't Riet E. Role of adiposity and lifestyle in the relationship between family history of diabetes and 20-year incidence of type 2 diabetes in U.S. women. Diabetes Care 2010; 33:763-7. doi: 10.2337/dc09-1586
4. 4. Yoon PW, Scheuner MT, Khoury MJ. Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med 2003; 24: 128-35. DOI: 10.1016/s0749-3797(02)00585-8
5. 5. Melmed S. Williams textbook of endocrinology.ed. t. Edition. 2011; ISBN:9781437736007
6. 6. Nasiri M. Association of G-2548A polymorphism in the promoter of leptin gene with plasma leptin level and risk of type 2 diabetes. J Kerman Uni Med Sci 2013; 4: 70-77.
7. 7. Fuchsberger C. The genetic architecture of type 2 diabetes. Nature 2016; 536:41-47. doi: 10.1038/nature18642
8. 8. Gaulton KJ. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet 2015; 47:1415-25. doi: 10.1038/ng.3437
9. 9. Wellen KE, Hotamisligil GS. Inflammation, stress and diabetes. J Clin Invest 2005; 115: 1111-9. doi: 10.1172/JCI25102
10. 10. Kannel WB. Lipids,diabetes and coronary heart disease. insights from the framingham study. Am Heart J 1985; 110:1100-7. doi: 10.1016/0002-8703(85)90224-8
11. 11. Taskinen MR. Diabetic dyslipidaemia. from basic research to clinical practice. Diabetologia 2003; 46:733-49. doi.org/10.1007/s00125-003-1111-y
12. 12. Solano MP, Goldberg RB. Management of dyslipidemia in diabetes. Cardiol Rev 2006; 14: 125-35. doi: 10.1097/01.crd.0000188034.76283.5e
13. 13. Ishimura S. Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population. PLoS One 2013; 8:e81318. doi.org/10.1371/journal.pone.0081318
14. 14. Furuhashi M. Fatty acid binding protein 4 (FABP4). pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases. Clin Med Insights Cardiol 2014; 8:23-33. doi: 10.4137/CMC.S17067
15. 15. Hotamisligil GS, Bernlohr DA. Metabolic functions of FABPs--mechanisms and therapeutic implications. Nat Rev Endocrinol 2015; 11:592-605. doi: 10.1038/nrendo.2015.122
16. 16. medicine Nlo. rs8192688. dbSNP. 2020.
17. 17. Medrano RFV, de Oliveira CA. Guidelines for the tetra-primer ARMS-PCR technique development. Mol biotech 2014; 56:599-608. doi: 10.1007/s12033-014-9734-4
18. 18. Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 2009; 53: S35-42. doi: 10.1016/j.jacc.2008.09.055
19. 19. Matheus AS. Impact of diabetes on cardiovascular disease. an update. Int J Hypertens 2013; 653789. doi: 10.1155/2013/653789
20. 20. Watts GF, Playford DA. Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus. an hypothesis. Atherosclerosis 1998; 141: 17-30. doi: 10.1016/s0021-9150 (98)00170-1
21. 21. Daousi C. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Postgrad Med J 2006; 82:280-4. doi: 10.1136/pmj.2005.039032
22. 22. Senemar S, Edraki MR, Toosi S. Association between type 2 diabetes mellitus, biochemical factors and UCSNP-43 polymorphisms of CALPIN-10 gene in patients with atherosclerosis of coronary artery disease in Southern Iran population. J Cardiovasc Thorac Res 2016; 8:13-9. doi: 10.15171/jcvtr.2016.03
23. 23. Zadhoush F, Sadeghi M, Pourfarzam M. Biochemical changes in blood of type 2 diabetes with and without metabolic syndrome and their association with metabolic syndrome components. J Res Med Sci 2015; 20:763-70. doi: 10.4103/1735-1995.168383
24. 24. Sattar N, Wannamethee SG, Forouhi NG. Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? Diabetologia 2008. 51: p. 926-940. doi: 10.1007/s00125-008-0954-7
25. 25. Adela R. Serum protein signature of coronary artery disease in type 2 diabetes mellitus. J Transl Med 2019; 17:17. doi.org/10.1186/s12967-018-1755-5
26. 26. Ye X. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Cardio Diabet 2019; 18:48. doi.org/10.1186/s12933-019-0851-z
27. 27. Kaftan A, Hussain M. Association of Adiponectin Gene Polymorphism rs266729 with Type Two Diabetes Mellitus in Iraqi Population. a pilot Study. Gene 2015; 570. doi: 10.1016/j.gene.2015.06.004
28. 28. Kannel WB. Lipids, diabetes, and coronary heart disease: Insights from the Framingham Study. American Heart J 1985;110:1100-107. doi: 10.1016/0002-8703(85)90224-8
29. 29. Wu Z. Different associations between HDL cholesterol and cardiovascular diseases in people with diabetes mellitus and people without diabetes mellitus. a prospective community-based study. American J Clinical Nutrition 2021; 114:907-13. doi: 10.1093/ajcn/nqab163
30. 30. Mansego ML. Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish population. PLoS One 2012; 7:e31853. doi.org/10.1371/journal.pone.0031853
31. 31. Ibarretxe D. FABP4 plasma concentrations are determined by acquired metabolic derangements rather than genetic determinants. Nutr Metab Cardiovasc Dis 2015; 25:875-80. doi: 10.1016/j.numecd.2015.05.008.
Send email to the article author

Add your comments about this article
Your username or Email:


Ethics code: IR.IAU.SHK.REC.1399.011

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bakhtiyari A, Bakhtiari S, Peymani M, Haghani K, Norozi S. Investigation of the Relationship between the rs8192688 Polymorphism of the FABP-4 Gene and Cardiovascular Disease Susceptibility in Type 2 Diabetic Patients in Ilam Province, Iran. J. Ilam Uni. Med. Sci. 2022; 30 (2) :97-104
URL: http://sjimu.medilam.ac.ir/article-1-7189-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 30, Issue 2 (6-2022) Back to browse issues page
مجله دانشگاه علوم پزشکی ایلام Journal of Ilam University of Medical Sciences
Persian site map - English site map - Created in 0.16 seconds with 41 queries by YEKTAWEB 4613